Chugai Pharmaceutical

Contact
chugai-pharm.co.jp
+813-3281-6611

Chugai Pharmaceutical Co., Ltd.

1-1 Nihonbashi-Muromachi 2-Chome, Chuo-ku
103-8324 Tokio
Japan

Phone

chugai-pharm.co.jp
Contact
Profile Products News
Contact

About Chugai Pharmaceutical

Read more about Chugai Pharmaceutical
Facts about Chugai Pharmaceutical
  • Industry : Pharma

Product portfolio of Chugai Pharmaceutical

Product portfolio

Show all

News about Chugai Pharmaceutical

Chugai Pharmaceutical

15-Jan-2025 | business & finance

Araris Biotech announces research collaboration and option to license agreement with Chugai Pharmaceutical Co.

Araris to receive an upfront fee and milestone payments potentially totalling USD 780 million plus royalties on net product sales

Read news
Chugai Pharmaceutical

02-Jun-2009 | business & finance

Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd.

Gene Bridges GmbH announced that Chugai Pharmaceutical Co., Ltd. of Tokyo, Japan has completed the amendment to expand the commercial license agreement ...

Read news
Chugai Pharmaceutical

19-Apr-2006 | research and development

OSI Pharmaceuticals Announces Submission of New Drug Application for Tarceva(R) in Japan

OSI Pharmaceuticals, Inc. announced that a New Drug Application has been submitted in Japan covering the use of its flagship product, Tarceva(R) (erlotinib ...

Read news
Chugai Pharmaceutical

23-Feb-2006 | business & finance

Cambrex Licenses Cell Line to Chugai Pharmaceutical Co.

Cambrex Bio Science Walkersville, Inc., a subsidiary of Cambrex, announced that its client Chugai Pharmaceutical Co., Ltd. completed their assessment of ...

Read news
Chugai Pharmaceutical

03-Nov-2005 | science

Collaborative Search for Microorganisms in Vietnam

The National Institute of Technology and Evaluation (NITE), Astellas Pharma Inc. and Chugai Pharmaceutical Co., Ltd. will start the first industry- ...

Read news
Chugai Pharmaceutical

05-Oct-2005 | business & finance

Cambrex Licenses Cell Lines to Chugai Pharmaceutical Co.

Cambrex Bioscience Walkersville, Inc., a subsidiary of Cambrex Corporation, announced that they have signed an evaluation license agreement with Chugai ...

Read news
Show more news about Chugai Pharmaceutical

Here you will find Chugai Pharmaceutical Co., Ltd.